SNNA

Sienna Biopharmaceuticals, Inc.
SNNA

Delisted

SNNA was delisted on the 16th of December, 2019.

53 hedge funds and large institutions have $151M invested in Sienna Biopharmaceuticals, Inc. in 2018 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 27 increasing their positions, 10 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
53
Holders Change
+1
Holders Change %
+1.92%
% of All Funds
1.22%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
8
Increased
27
Reduced
10
Closed
7
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
PIA
51
Piedmont Investment Advisors
North Carolina
$4K +$4K +268 New
Daiwa Securities Group
52
Daiwa Securities Group
Japan
$2K
TCM
53
TimesSquare Capital Management
New York
-$6.77M -360,200 Closed
Norges Bank
54
Norges Bank
Norway
-$751K -40,000 Closed
PPA
55
Parametric Portfolio Associates
Washington
-$191K -10,197 Closed
MIM
56
MetLife Investment Management
New Jersey
-$147K -7,806 Closed
MLICM
57
Metropolitan Life Insurance Company (MetLife)
New York
-$103K -5,489 Closed
SO
58
STRS Ohio
Ohio
-$80K -4,300 Closed
Citigroup
59
Citigroup
New York
-$40K -2,163 Closed